Alopecia areata - I-Alopecia Areatahttps://en.wikipedia.org/wiki/Alopecia_areata
I- I-Alopecia Areata (Alopecia areata) yisimo sendawo lapho izinwele zilahleka khona emzimbeni. Ngokuvamile, kubangela amabala empandla ambalwa ekhanda, ngalinye lilingane nohlamvu lwemali. Lesi sifo singabangelwa ukucindezeleka kwengqondo.

I-Alopecia areata kukholakala ukuthi iyisifo esizimele esihlobene namasosha omzimba ezinhlayiya zezinwele. Indlela eyisisekelo ihlanganisa ukwehluleka komzimba ukubona amangqamuzana awo, nokubhujiswa okulandelayo kwe-immune-mediated ye-follicle yezinwele.

Ukwelashwa - Izidakamizwa ze-OTC
Abanye abantu abane-alopecia areata ethambile bayalulama ungakapheli unyaka ngaphandle kokwelashwa. Kodwa-ke, abantu abaningi bahlangabezana nokuphindaphinda kumasayithi angahleliwe ekhanda.
#Hydrocortisone cream

Ukwelashwa
Imijovo ye-Intralesional steroid iyindlela yokwelapha ephumelela kakhulu. I-Immunotherapy ingazanywa uma izindawo ezinkulu ze-scalp zithinteka.
#Triamcinolone intralesional injection
#DPCP immunotherapy
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
  • I-Alopecia Areata (Alopecia areata) ibonakala ngemuva kwesikhumba. Ezimweni ezijwayelekile, kuvela ngokuzumayo nge-surface ebushelelezi ngokuphelele kanye nosayizi we-2-3 cm.
  • Ukulahlekelwa izinwele eziyindilinga eziningi
References Alopecia areata 28300084 
NIH
I- Alopecia areata yisimo lapho amasosha akho omzimba ehlasela izimpande zezinwele zakho, okuholela ekuqothukeni kwezinwele zesikhashana ngaphandle kwezibazi. Kungavela njengamabala okulahlekelwa izinwele noma kuthinte isikhumba sakho sonke noma umzimba wakho, kuthinte cishe u-2% wabantu esikhathini esithile empilweni yabo. Icala eliyinhloko libonakala liwukuwohloka ekuvikelweni kwemvelo okuzungeze izimpande zezinwele.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
 Alopecia Areata: An Updated Review for 2023 37340563 
NIH
Alopecia areata yisimo lapho amasosha omzimba ehlasela khona izinhlayiya zezinwele, okubangela ukuqothuka kwezinwele esikhunjeni sekhanda nezinye izingxenye zomzimba ezinoboya. Kuthinta cishe u-2% wabantu emhlabeni jikelele. Nakuba kungenzeka kunoma iyiphi iminyaka, ivame kakhulu ezinganeni kunabantu abadala (1. 92% vs. 1. 47%) . Abesifazane, ikakhulukazi labo abangaphezu kweminyaka engama-50, bavame ukuba nakho ngaphezu kwabesilisa. Ukujova ama-corticosteroids ngqo ezindaweni ezithintekile kubonise imiphumela engcono kunokuwasebenzisa ngokwezihloko.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.